The guy you may be thinking of was actually involved with an AIDS drug. The Epi-Pen controversy involved the company, Mylan. From Fortune.
Martin Shkreli—famously known as the guy that jacked up the price of a lifesaving AIDS treatment by 5,000%—finally saw his day in court, albeit for a completely unrelated case involving an unrelated company from his time as a hedge fund manager. The trial, just concluded last week, found Shkreli guilty of three counts of fraud for essentially lying to his investors about how he would invest their money and when they would be paid back.
The conviction, carrying a potential 20 years in prison, is no joke. Yet the notorious self-promoter took the opportunity to extend his 15 minutes of fame by creating a media spectacle of the trial. From making silly faces in court, to trolling female journalists online, to referring to the prosecution as “junior varsity,” the Pharma Bro let the world know he wasn’t fazed.